53Biologics, a CDMO specializing in biologics production and cGMP manufacturing, opened a new GMP production line for microbial-based therapeutics. The new production line boasts a 2000L reactor. The new addition to 53Biologics’s manufacturing facility allow them to meet the growing demand for microbial-based products and serve more clients across the globe. In addition to the 2000L reactor, the new GMP production line is equipped with a range of single-use downstream equipment, includi...